MIST PPF Study active, not recruiting

Learn More

Phase 2 AURA-IPF Study

A Phase 2 Study Evaluating the Safety and Efficacy of AP02 (inhaled nintedanib) in Participants with Idiopathic Pulmonary Fibrosis (IPF)

View our Poster at ERS 2025

visit study #NCT07194382 clinical trials.GOV >